The company holds a license agreement with Maruho for the Maruho License Product, granting rights related to pharmaceutical, biologic, or medical device products developed by or on behalf of the company or its affiliates using the compound ASP7266 in Japan. The company manages global research and development for this product. Additionally, the company has a license agreement with Lonza Sales AG, providing a worldwide, non-exclusive, sublicensable license to use Lonza's glutamine synthetase gene expression system for the development, manufacture, and commercialization of the compound. Under this agreement, the company is obligated to pay Lonza royalties and annual fees based on manufacturing and sales, with terms varying by country and extending until ten years after the first commercial sale in each respective country. The Lonza License Agreement remains in effect indefinitely unless terminated by either party under specified conditions.
Upstream Bio Inc's Comment on Supply Chain
The company holds a license agreement with Maruho for the Maruho License Product, granting rights related to pharmaceutical, biologic, or medical device products developed by or on behalf of the company or its affiliates using the compound ASP7266 in Japan. The company manages global research and development for this product. Additionally, the company has a license agreement with Lonza Sales AG, providing a worldwide, non-exclusive, sublicensable license to use Lonza's glutamine synthetase gene expression system for the development, manufacture, and commercialization of the compound. Under this agreement, the company is obligated to pay Lonza royalties and annual fees based on manufacturing and sales, with terms varying by country and extending until ten years after the first commercial sale in each respective country. The Lonza License Agreement remains in effect indefinitely unless terminated by either party under specified conditions.
Sources:
Upstream Bio Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Upstream Bio Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
